ACHC
Acadia Healthcare Company, Inc. NASDAQ Listed Mar 4, 1994$24.45
After hrs
$25.21
+0.12%
Mkt Cap $2.2B
52w Low $11.43
69.4% of range
52w High $30.20
50d MA $25.05
200d MA $20.40
P/E (TTM)
-2.3x
EV/EBITDA
-5.2x
P/B
1.2x
Debt/Equity
1.4x
ROE
-56.6%
P/FCF
-2.9x
RSI (14)
—
ATR (14)
—
Beta
0.71
50d MA
$25.05
200d MA
$20.40
Avg Volume
3.4M
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
6100 Tower Circle · Franklin, TN 37067 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 0.28 | 0.37 | +32.1% | 28.26 | -4.0% | -8.4% | -1.5% | -2.0% | -10.6% | -10.5% | — |
| Feb 25, 2026 | AMC | 0.03 | 0.07 | +133.3% | 20.84 | +1.8% | +7.0% | +12.5% | +12.5% | +10.3% | +15.5% | — |
| Nov 5, 2025 | AMC | 0.68 | 0.72 | +5.9% | 20.68 | -8.1% | -2.0% | -5.7% | -12.1% | -11.8% | -15.8% | — |
| Aug 5, 2025 | AMC | 0.71 | 0.83 | +16.9% | 21.76 | -4.5% | -17.3% | -16.4% | -11.6% | -12.4% | -6.6% | — |
| May 12, 2025 | AMC | 0.35 | 0.40 | +14.3% | 25.84 | +1.6% | +4.3% | -0.5% | -0.8% | +1.2% | -2.9% | — |
| Feb 27, 2025 | AMC | 0.75 | 0.64 | -14.7% | 40.26 | -19.3% | -25.5% | -27.3% | -24.3% | -26.3% | -25.7% | — |
| Oct 30, 2024 | AMC | 0.90 | 0.91 | +1.1% | 52.08 | -12.6% | -18.0% | -19.3% | -18.7% | -18.4% | -18.4% | — |
| Jul 31, 2024 | AMC | 0.87 | 0.91 | +4.6% | 64.85 | +6.8% | +14.2% | +11.6% | +9.5% | +9.4% | +9.1% | — |
| May 1, 2024 | AMC | 0.81 | 0.84 | +3.7% | 72.99 | -3.9% | -8.6% | -9.4% | -7.1% | -7.6% | -9.5% | — |
| Feb 27, 2024 | AMC | 0.80 | 0.85 | +6.2% | 87.38 | -0.8% | -4.5% | -4.5% | -3.9% | -2.0% | -3.0% | — |
| Nov 2, 2023 | AMC | 0.88 | 0.91 | +3.4% | 73.24 | +2.6% | -1.4% | +0.4% | +1.4% | +0.6% | -1.4% | — |
| Jul 27, 2023 | AMC | 0.86 | 0.92 | +7.0% | 73.36 | +6.2% | +8.3% | +7.7% | +7.0% | +7.4% | +5.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4 | Raymond James | Upgrade | Outperform → Strong Buy | $39 | $27.85 | $29.38 | +5.5% | -0.6% | -9.3% | -9.2% | -12.2% | — |
| May 1 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $25.90 | $25.79 | -0.4% | +7.5% | +6.9% | -2.4% | -2.3% | -5.6% |
| May 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $25.90 | $25.79 | -0.4% | +7.5% | +6.9% | -2.4% | -2.3% | -5.6% |
| Apr 28 | TD Cowen | Maintains | Buy → Buy | — | $28.15 | $28.42 | +1.0% | -2.0% | +0.4% | -8.0% | -1.1% | -1.6% |
| Apr 17 | UBS | Maintains | Buy → Buy | — | $26.89 | $27.00 | +0.4% | +0.4% | +3.5% | +2.0% | +4.2% | +1.7% |
| Mar 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.44 | $22.84 | -2.6% | -1.9% | +2.7% | +5.2% | +9.3% | +5.4% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $20.84 | $21.22 | +1.8% | +7.0% | +12.5% | +12.5% | +10.3% | +15.5% |
| Feb 26 | UBS | Maintains | Buy → Buy | — | $20.84 | $21.22 | +1.8% | +7.0% | +12.5% | +12.5% | +10.3% | +15.5% |
| Feb 26 | Leerink Partners | Maintains | Market Perform → Market Perform | — | $20.84 | $21.22 | +1.8% | +7.0% | +12.5% | +12.5% | +10.3% | +15.5% |
| Feb 26 | TD Cowen | Maintains | Buy → Buy | — | $20.84 | $21.22 | +1.8% | +7.0% | +12.5% | +12.5% | +10.3% | +15.5% |
| Feb 23 | Guggenheim | Maintains | Buy → Buy | — | $16.79 | $16.65 | -0.8% | +3.5% | +2.3% | +24.1% | +32.8% | +39.6% |
| Jan 22 | Jefferies | Downgrade | Buy → Hold | — | $14.33 | $13.85 | -3.3% | +5.7% | +6.3% | +6.3% | -5.9% | -6.2% |
| Jan 16 | TD Cowen | Maintains | Buy → Buy | — | $11.91 | $11.86 | -0.4% | -1.9% | +19.6% | +20.3% | +27.2% | +27.9% |
| Jan 14 | RBC Capital | Maintains | Outperform → Outperform | — | $12.55 | $12.49 | -0.5% | -6.5% | -5.1% | -6.9% | +13.5% | +14.2% |
| Dec 18 | Mizuho | Maintains | Neutral → Neutral | — | $14.53 | $14.48 | -0.3% | -0.7% | -0.8% | -0.5% | -3.0% | -1.6% |
| Dec 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $14.69 | $14.73 | +0.3% | -0.3% | +5.3% | -4.7% | -4.6% | -6.4% |
| Dec 3 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $16.49 | $12.89 | -21.8% | -10.9% | -11.2% | -6.2% | -15.1% | -15.0% |
| Dec 3 | Deutsche Bank | Maintains | Buy → Buy | — | $16.49 | $12.89 | -21.8% | -10.9% | -11.2% | -6.2% | -15.1% | -15.0% |
| Dec 3 | UBS | Maintains | Buy → Buy | — | $16.49 | $12.89 | -21.8% | -10.9% | -11.2% | -6.2% | -15.1% | -15.0% |
| Dec 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $16.49 | $12.89 | -21.8% | -10.9% | -11.2% | -6.2% | -15.1% | -15.0% |
| Dec 3 | BofA Securities | Downgrade | Neutral → Underperform | — | $16.49 | $12.89 | -21.8% | -10.9% | -11.2% | -6.2% | -15.1% | -15.0% |
| Dec 3 | Leerink Partners | Downgrade | Outperform → Market Perform | — | $16.49 | $12.89 | -21.8% | -10.9% | -11.2% | -6.2% | -15.1% | -15.0% |
| Dec 3 | RBC Capital | Maintains | Outperform → Outperform | — | $16.49 | $12.89 | -21.8% | -10.9% | -11.2% | -6.2% | -15.1% | -15.0% |
| Nov 18 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $15.65 | $15.65 | +0.0% | -4.1% | -8.4% | -8.2% | -3.0% | -0.7% |
| Nov 12 | RBC Capital | Maintains | Outperform → Outperform | — | $18.24 | $18.20 | -0.2% | -4.6% | -11.8% | -12.2% | -14.2% | -17.7% |
| Nov 10 | Guggenheim | Maintains | Buy → Buy | — | $19.51 | $19.19 | -1.6% | -6.9% | -6.5% | -10.8% | -17.6% | -17.9% |
| Nov 7 | UBS | Maintains | Buy → Buy | — | $20.26 | $19.75 | -2.5% | -3.7% | -10.3% | -10.0% | -14.1% | -20.6% |
| Nov 7 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $20.26 | $19.75 | -2.5% | -3.7% | -10.3% | -10.0% | -14.1% | -20.6% |
| Nov 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $20.68 | $19.00 | -8.1% | -2.0% | -5.7% | -12.1% | -11.8% | -15.8% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $27.23 | $26.74 | -1.8% | -6.0% | -7.5% | -10.9% | -10.8% | -8.4% |
| Oct 7 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $26.46 | $26.70 | +0.9% | +2.9% | -3.3% | -4.8% | -8.3% | -8.2% |
| Oct 3 | Raymond James | Maintains | Outperform → Outperform | — | $26.62 | $26.53 | -0.3% | +2.0% | -0.6% | +2.3% | -3.8% | -5.4% |
| Sep 10 | BofA Securities | Downgrade | Buy → Neutral | — | $23.30 | $22.64 | -2.8% | -9.6% | -4.2% | -6.7% | -8.1% | -6.8% |
| Aug 14 | Raymond James | Downgrade | Strong Buy → Outperform | — | $20.77 | $19.92 | -4.1% | -0.5% | +1.0% | +1.7% | +3.9% | +2.6% |
| Aug 14 | Mizuho | Maintains | Neutral → Neutral | — | $20.77 | $19.92 | -4.1% | -0.5% | +1.0% | +1.7% | +3.9% | +2.6% |
| Aug 13 | RBC Capital | Maintains | Outperform → Outperform | — | $20.33 | $20.25 | -0.4% | +2.2% | +1.6% | +3.2% | +3.9% | +6.2% |
| Aug 7 | Guggenheim | Maintains | Buy → Buy | — | $18.00 | $18.17 | +0.9% | +1.1% | +6.9% | +5.9% | +12.9% | +15.4% |
| Aug 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.00 | $18.17 | +0.9% | +1.1% | +6.9% | +5.9% | +12.9% | +15.4% |
| Aug 7 | UBS | Maintains | Buy → Buy | — | $18.00 | $18.17 | +0.9% | +1.1% | +6.9% | +5.9% | +12.9% | +15.4% |
| Aug 7 | TD Cowen | Maintains | Buy → Buy | — | $18.00 | $18.17 | +0.9% | +1.1% | +6.9% | +5.9% | +12.9% | +15.4% |
| May 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $26.94 | $27.00 | +0.2% | -4.5% | -4.8% | -2.9% | -6.9% | -6.5% |
| May 14 | Mizuho | Maintains | Neutral → Neutral | — | $26.94 | $27.00 | +0.2% | -4.5% | -4.8% | -2.9% | -6.9% | -6.5% |
| May 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $26.94 | $27.00 | +0.2% | -4.5% | -4.8% | -2.9% | -6.9% | -6.5% |
| May 13 | BofA Securities | Maintains | Buy → Buy | — | $25.84 | $26.26 | +1.6% | +4.3% | -0.5% | -0.8% | +1.2% | -2.9% |
| Apr 3 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $29.21 | $28.70 | -1.7% | -2.8% | -6.3% | -9.6% | -7.2% | -0.4% |
| Mar 25 | Mizuho | Maintains | Neutral → Neutral | — | $28.94 | $29.06 | +0.4% | -0.4% | +2.5% | +4.1% | +4.1% | +4.8% |
| Mar 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $29.98 | $30.46 | +1.6% | -2.4% | +1.6% | -1.0% | -0.2% | +2.0% |
| Mar 3 | RBC Capital | Maintains | Outperform → Outperform | — | $29.98 | $30.46 | +1.6% | -2.4% | +1.6% | -1.0% | -0.2% | +2.0% |
| Feb 28 | Barclays | Downgrade | Overweight → Equal Weight | — | $40.26 | $32.50 | -19.3% | -25.5% | -27.3% | -24.3% | -26.3% | -25.7% |
| Feb 28 | BofA Securities | Maintains | Buy → Buy | — | $40.26 | $32.50 | -19.3% | -25.5% | -27.3% | -24.3% | -26.3% | -25.7% |
No insider trades available.
8-K · 7.01
! Medium
Acadia Healthcare Company, Inc. -- 8-K 7.01: Regulation FD Disclosure
Acadia Healthcare announced a Chief Financial Officer transition on April 23, 2026, signaling potential strategic shifts in financial management and company direction.
Apr 23
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Without seeing the actual press release content, I cannot provide specific analysis; however, investors should review Exhibit 99.1 immediately to assess whether disclosed matters affect earnings guidance, operations, or competitive positioning.
Mar 12
8-K · 7.01
! Medium
Acadia Healthcare Company, Inc. -- 8-K 7.01: Regulation FD Disclosure
Acadia Healthcare will host a February 25, 2026 earnings call to discuss fourth-quarter 2025 results, with presentation slides available for investor reference.
Feb 25
Data updated apr 24, 2026 10:31am
· Source: massive.com